ArticleAntimicrobial resistance and infection control2025
Implementation and impact of a business intelligence system on catheter-related bloodstream infections: a multicenter experience.
Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCentral-line-associated bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI) are associated with increased mortality and healthcare costs. We describe implementing a hospital-wide business intelligence (BI) system coupled with infectious disease (ID) specialist intervention to support proactive CRBSI surveillance.
methodsWe conducted a multicenter, retrospective analysis of a quality improvement initiative from January 2019 to September 2024. A BI system used predefined criteria (leukocytosis, elevated C-reactive protein, prolonged catheter duration, and fever) to identify high-risk patients. Starting in July 2022, ID specialists reviewed these cases and provided advice on catheter reassessment. We employed interrupted time series (ITS) analysis to evaluate quarterly trends in CRBSI incidence and mean central venous catheter (CVC) duration, adjusting for seasonality and conducting a stratified analysis for ICU versus non-ICU settings.
resultsA total of 5090 patients with 6,750 CVC placements were included. While the overall trend for CRBSI incidence was not significantly affected by the intervention, the stratified analysis showed a statistically significant decrease in the CRBSI incidence trend within the ICU setting (slope change Δ = - 0.737/quarter, P = 0.045). No significant change was seen in the non-ICU setting. The intervention's effect on average CVC duration was less evident, with varied and often non-significant changes across different sites.
conclusionA hospital-wide BI system, combined with ID specialist expertise, was associated with a significant reduction in CRBSI incidence over time, especially in the high-risk ICU setting. This technology-focused, expert-supported approach offers a promising approach to improving patient safety and infection control outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.